Prolonged QT interval with rivastigmine

Br J Psychiatry. 2002 May:180:466. doi: 10.1192/bjp.180.5.466-a.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Alzheimer Disease / drug therapy
  • Carbamates / adverse effects*
  • Cholinesterase Inhibitors / adverse effects*
  • Humans
  • Long QT Syndrome / chemically induced*
  • Male
  • Neuroprotective Agents / adverse effects*
  • Phenylcarbamates*
  • Rivastigmine

Substances

  • Carbamates
  • Cholinesterase Inhibitors
  • Neuroprotective Agents
  • Phenylcarbamates
  • Rivastigmine